Alsallaq RA, Baeten JM, Celum CL, Hughes JP, Abu-Raddad LJ, Barnabas RV, et al. Understanding the Potential Impact of a Combination HIV Prevention Intervention in a Hyper-Endemic Community. PloS one. 2013;8(1):e54575.
http://www.ncbi.nlm.nih.gov/pubmed/23372738?otool=fhcrclib
Auranen K, Rinta-Kokko H, Halloran ME. Estimating Strain-Specific and Overall Efficacy of Polyvalent Vaccines Against Recurrent Pathogens From a Cross-Sectional Study. Biometrics. 2013.
http://www.ncbi.nlm.nih.gov/pubmed/23379663?otool=fhcrclib
Baddley JW, Andes DR, Marr KA, Kauffman CA, Kontoyiannis DP, Ito JI, et al. Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis. Medical mycology : official publication of the International Society for Human and Animal Mycology. 2013;51(25):128-35.
http://www.ncbi.nlm.nih.gov/pubmed/22680976?otool=fhcrclib
Baggaley RF, Dimitrov D, Owen BN, Pickles M, Butler AR, Masse B, et al. Heterosexual Anal Intercourse: A Neglected Risk Factor for HIV? Am J Reprod Immunol. 2013;69 Suppl 1:95-105.
http://www.ncbi.nlm.nih.gov/pubmed/23279040?otool=fhcrclib
Barouch DH, Liu J, Peter L, Abbink P, Iampietro MJ, Cheung A, et al. Characterization of Humoral and Cellular Immune Responses Elicited by a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine in Healthy Adults (IPCAVD 001). The Journal of infectious diseases. 2013;207(2):248-56.
http://www.ncbi.nlm.nih.gov/pubmed/23125443?otool=fhcrclib
Bernstein DI, Bellamy AR, Hook EW, Levin MJ, Wald A, Ewell MG, et al. Epidemiology, Clinical Presentation, and Antibody Response to Primary Infection With Herpes Simplex Virus Type 1 and Type 2 in Young Women. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2013;56(3):344-51.
http://www.ncbi.nlm.nih.gov/pubmed/23087395?otool=fhcrclib
Campbell AP, Kuypers J, Englund JA, Guthrie KA, Corey L, Boeckh M. Self Collection of Foam Nasal Swabs for Respiratory Virus Detection by PCR among Immunocompetent Subjects and Hematopoietic Cell Transplant Recipients. J Clin Microbiol. 2013;51(1):324-7.
http://www.ncbi.nlm.nih.gov/pubmed/23135933?otool=fhcrclib
Chemaitelly H, Shelton JD, Hallett TB, Abu-Raddad LJ. Only a fraction of new HIV infections occur within identifiable stable discordant couples in sub-Saharan Africa. AIDS (London, England). 2013;27(2):251-60.
http://www.ncbi.nlm.nih.gov/pubmed/23079805?otool=fhcrclib
Cousins MM, Donnell D, Eshleman SH. Impact of mutation type and amplicon characteristics on genetic diversity measures generated using a high-resolution melting diversity assay. J Mol Diagn. 2013;15(1):130-7.
http://www.ncbi.nlm.nih.gov/pubmed/23178437?otool=fhcrclib
Dai JY, Gilbert PB, Hughes JP, Brown ER. Estimating the Efficacy of Preexposure Prophylaxis for HIV Prevention Among Participants With a Threshold Level of Drug Concentration. Am J Epidemiol. 2013;177(3):256-63.
http://www.ncbi.nlm.nih.gov/pubmed/23302152?otool=fhcrclib
Dimitrov DT, Mâsse BR, Boily M-C. Beating the placebo in HIV prevention efficacy trials: the role of the minimal efficacy bound. Journal of acquired immune deficiency syndromes (1999). 2013;62(1):95-101.
http://www.ncbi.nlm.nih.gov/pubmed/23075921?otool=fhcrclib
Donnell DJ, Baeten JM, Hong T, Lingappa JR, Mujugira A, Nakku-Joloba E, et al. Correlation Between Pill Counts and Biologic Effects in an HIV-1 Prevention Clinical Trial: Implications for Measuring Adherence. AIDS Behav. 2013;17(2):632-9.
http://www.ncbi.nlm.nih.gov/pubmed/22869103?otool=fhcrclib
Drozd DR, Limaye AP, Moss RB, Sanders RL, Hansen C, Edelman JD, et al. DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient. Transpl Infect Dis. 2013;15(1):E28-32.
http://www.ncbi.nlm.nih.gov/pubmed/23279859?otool=fhcrclib
Duerr A, Huang Y, Buchbinder S, Coombs RW, Sanchez J, del Rio C, et al. Reply to richie and villasante. The Journal of infectious diseases. 2013;207(4):690-2.
http://www.ncbi.nlm.nih.gov/pubmed/23204171?otool=fhcrclib
Eshleman SH, Hughes JP, Laeyendecker O, Wang J, Brookmeyer R, Johnson-Lewis L, et al. Use of a multi-faceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study. The Journal of infectious diseases. 2013;207(2):223-31.
http://www.ncbi.nlm.nih.gov/pubmed/23129758?otool=fhcrclib
Feng Z, Kagan J, Pepe M, Thornquist M, Ann Rinaudo J, Dahlgren J, et al. The Early Detection Research Network's Specimen Reference Sets: Paving the Way for Rapid Evaluation of Potential Biomarkers. Clin Chem. 2013;59(1):68-74.
http://www.ncbi.nlm.nih.gov/pubmed/23193062?otool=fhcrclib
Forthal DN, Landucci G, Chohan B, Richardson BA, Scott McClelland R, Jaoko W, et al. Antibody-dependent cell-mediated virus inhibition (ADCVI) antibody activity does not correlate with risk of HIV-1 superinfection. Journal of acquired immune deficiency syndromes (1999). 2013.
http://www.ncbi.nlm.nih.gov/pubmed/23344546?otool=fhcrclib
Gray GE, Metch B, Churchyard G, Mlisana K, Nchabeleng M, Allen M, et al. Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa? Vaccine. 2013.
http://www.ncbi.nlm.nih.gov/pubmed/23370155?otool=fhcrclib
Heffron R, Mugo N, Ngure K, Celum C, Donnell D, Were E, et al. Hormonal contraceptive use and risk of HIV-1 disease progression. AIDS (London, England). 2013;27(2):261-7.
http://www.ncbi.nlm.nih.gov/pubmed/23079806?otool=fhcrclib
Hendrix CW, Chen BA, Guddera V, Hoesley C, Justman J, Nakabiito C, et al. MTN-001: Randomized Pharmacokinetic Cross-Over Study Comparing Tenofovir Vaginal Gel and Oral Tablets in Vaginal Tissue and Other Compartments. PloS one. 2013;8(1):e55013.
http://www.ncbi.nlm.nih.gov/pubmed/23383037?otool=fhcrclib
Hirsch HH, Martino R, Ward KN, Boeckh M, Einsele H, Ljungman P. Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and Coronavirus. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2013;56(2):258-66.
http://www.ncbi.nlm.nih.gov/pubmed/23024295?otool=fhcrclib
Hodder SL, Justman J, Hughes JP, Wang J, Haley DF, Adimora AA, et al. HIV acquisition among women from selected areas of the United States: a cohort study. Ann Intern Med. 2013;158(1):10-8.
http://www.ncbi.nlm.nih.gov/pubmed/23277896?otool=fhcrclib
Hoot S, McGuire AT, Cohen KW, Strong RK, Hangartner L, Klein F, et al. Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs. PLoS Pathog. 2013;9(1):e1003106.
http://www.ncbi.nlm.nih.gov/pubmed/23300456?otool=fhcrclib
Jing L, Schiffer JT, Chong TM, Bruckner JJ, Davies DH, Felgner PL, et al. CD4 T-cell memory responses to viral infections of humans show pronounced immunodominance independent of duration or viral persistence. Journal of virology. 2013;87(5):2617-27.
http://www.ncbi.nlm.nih.gov/pubmed/23255792?otool=fhcrclib
Kharfan-Dabaja MA, Boeckh M, Wilck MB, Langston AA, Chu AH, Wloch MK, et al. Reanalysis of TransVax immunogenicity. The Lancet infectious diseases. 2013;13(1):18.
http://www.ncbi.nlm.nih.gov/pubmed/23257230?otool=fhcrclib
Laeyendecker O, Brookmeyer R, Cousins MM, Mullis CE, Konikoff J, Donnell D, et al. HIV Incidence Determination in the United States: A Multi-Assay Approach. The Journal of infectious diseases. 2013;207(2):232-9.
http://www.ncbi.nlm.nih.gov/pubmed/23129760?otool=fhcrclib
Langat A, Benki-Nugent S, Wamalwa D, Tapia K, Ngugi E, Diener L, et al. Lipid Changes in Kenyan HIV-1-Infected Infants Initiating Highly Active Antiretroviral Therapy by One Year of Age. The Pediatric infectious disease journal. 2013.
http://www.ncbi.nlm.nih.gov/pubmed/23385950?otool=fhcrclib
Latkin C, Donnell D, Liu T-Y, Davey-Rothwell M, Celentano D, Metzger D. The dynamic relationship between social norms and behaviors: the results of an HIV prevention network intervention for injection drug users. Addiction. 2013.
http://www.ncbi.nlm.nih.gov/pubmed/23362861?otool=fhcrclib
Lingappa J, Thomas KK, Hughes JP, Baeten JM, Wald A, Farquhar C, et al. Partner characteristics predicting HIV-1 setpoint in sexually acquired HIV-1 among African seroconverters. AIDS research and human retroviruses. 2013;29(1):164-71.
http://www.ncbi.nlm.nih.gov/pubmed/23061422?otool=fhcrclib
Liu MKP, Hawkins N, Ritchie AJ, Ganusov VV, Whale V, Brackenridge S, et al. Vertical T cell immunodominance and epitope entropy determine HIV-1 escape. The Journal of clinical investigation. 2013;123(1):380-93.
http://www.ncbi.nlm.nih.gov/pubmed/23221345?otool=fhcrclib
McElrath M, Smythe K, Randolph-Habecker J, Melton K, Goodpaster T, Hughes S, et al. Comprehensive assessment of HIV target cells in the distal human gut suggests increasing HIV susceptibility toward the anus. Journal of acquired immune deficiency syndromes (1999). 2013.
http://www.ncbi.nlm.nih.gov/pubmed/23392465?otool=fhcrclib
Minnis AM, Gandham S, Richardson BA, Guddera V, Chen BA, Salata R, et al. Adherence and Acceptability in MTN 001: A Randomized Cross-Over Trial of Daily Oral and Topical Tenofovir for HIV Prevention in Women. AIDS Behav. 2013;17(2):737-47.
http://www.ncbi.nlm.nih.gov/pubmed/23065145?otool=fhcrclib
Mitchell C, Balkus JE, Fredricks D, Liu C, McKernan-Mullin J, Frenkel LM, et al. Interaction Between Lactobacilli, Bacterial Vaginosis-Associated Bacteria, and HIV Type 1 RNA and DNA Genital Shedding in U.S. and Kenyan Women. AIDS research and human retroviruses. 2013;29(1):13-9.
http://www.ncbi.nlm.nih.gov/pubmed/23020644?otool=fhcrclib
Mitchell C, Gottsch ML, Liu C, Fredricks DN, Nelson DB. Associations between vaginal bacteria and levels of vaginal defensins in pregnant women. Am J Obstet Gynecol. 2013;208(2):132e.1-7.
http://www.ncbi.nlm.nih.gov/pubmed/23174285?otool=fhcrclib
Munro SB, Kuypers J, Jerome KR. Comparison of a Multiplex Real-Time PCR Assay with a Multiplex Luminex Assay for Influenza Virus Detection. J Clin Microbiol. 2013.
http://www.ncbi.nlm.nih.gov/pubmed/23345299?otool=fhcrclib
Peterson CW, Younan P, Jerome KR, Kiem H-P. Combinatorial anti-HIV gene therapy: using a multipronged approach to reach beyond HAART. Gene Ther. 2013.
http://www.ncbi.nlm.nih.gov/pubmed/23364313?otool=fhcrclib
Pfeiffer J, Beschta J, Hohl S, Gloyd S, Hagopian A, Wasserheit J. Competency-based curricula to transform global health: redesign with the end in mind. Acad Med. 2013;88(1):131-6.
http://www.ncbi.nlm.nih.gov/pubmed/23165274?otool=fhcrclib
Quinn KM, Da Costa A, Yamamoto A, Berry D, Lindsay RWB, Darrah PA, et al. Comparative Analysis of the Magnitude, Quality, Phenotype, and Protective Capacity of Simian Immunodeficiency Virus Gag-Specific CD8+ T Cells following Human-, Simian-, and Chimpanzee-Derived Recombinant Adenoviral Vector Immunization. Journal of immunology (Baltimore, Md : 1950). 2013;190(6):2720-35.
http://www.ncbi.nlm.nih.gov/pubmed/23390298?otool=fhcrclib
Richardson BA, Kelly C, Ramjee G, Fleming T, Makanani B, Roberts S, et al. Appropriateness of hydroxyethylcellulose gel as a placebo control in vaginal microbicide trials: A comparison of the two control arms of HPTN 035. Journal of acquired immune deficiency syndromes (1999). 2013.
http://www.ncbi.nlm.nih.gov/pubmed/23334506?otool=fhcrclib
Roxby AC, Liu AY, Drake AL, Kiarie JN, Richardson B, Lohman-Payne BL, et al. T Cell Activation in HIV-1/Herpes Simplex Virus-2-Coinfected Kenyan Women Receiving Valacyclovir. AIDS research and human retroviruses. 2013;29(1):94-8.
http://www.ncbi.nlm.nih.gov/pubmed/22852760?otool=fhcrclib
Sedlak RH, Jerome KR. Viral diagnostics in the era of digital polymerase chain reaction. Diagn Microbiol Infect Dis. 2013;75(1):1-4.
http://www.ncbi.nlm.nih.gov/pubmed/23182074?otool=fhcrclib
Seo S, Campbell AP, Xie H, Chien JW, Leisenring WM, Englund JA, et al. Outcome of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Hematopoietic Cell Transplant Recipients Receiving Aerosolized Ribavirin: Significance of Stem Cell Source and Oxygen Requirement. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2013.
http://www.ncbi.nlm.nih.gov/pubmed/23298855?otool=fhcrclib
Sun Y, Li M, Gilbert PB. Mark-specific proportional hazards model with multivariate continuous marks and its application to HIV vaccine efficacy trials. Biostatistics (Oxford, England). 2013;14(1):60-74.
http://www.ncbi.nlm.nih.gov/pubmed/22764174?otool=fhcrclib
Tan WG, Jin H-T, West EE, Penaloza-Macmaster P, Wieland A, Zilliox MJ, et al. Comparative Analysis of Simian Immunodeficiency Virus Gag-Specific Effector and Memory CD8+ T Cells Induced by Different Adenovirus Vectors. Journal of virology. 2013;87(3):1359-72.
http://www.ncbi.nlm.nih.gov/pubmed/23175355?otool=fhcrclib
Tennant BR, Robertson AG, Kramer M, Li L, Zhang X, Beach M, et al. Identification and analysis of murine pancreatic islet enhancers. Diabetologia. 2013;56(3):542-52.
http://www.ncbi.nlm.nih.gov/pubmed/23238790?otool=fhcrclib
Wagner TA, Lin C-H, Tobin NH, Côté HCF, Sloan DD, Jerome KR, et al. Quantification of mitochondrial toxicity in HIV-infected individuals by quantitative PCR compared to flow cytometry. Cytometry B Clin Cytom. 2013;84B(1):55-8.
http://www.ncbi.nlm.nih.gov/pubmed/23044657?otool=fhcrclib
Walson JL, Sangaré LR, Singa BO, Naulikha JM, Piper BKS, Yuhas K, et al. Evaluation of impact of long-lasting insecticide-treated bed nets and point-of-use water filters on HIV-1 disease progression in Kenya. AIDS (London, England). 2013.
http://www.ncbi.nlm.nih.gov/pubmed/23324658?otool=fhcrclib
Xu M, Qin X, Astion ML, Rutledge JC, Simpson J, Jerome KR, et al. Implementation of filmarray respiratory viral panel in a core laboratory improves testing turnaround time and patient care. Am J Clin Pathol. 2013;139(1):118-23.
http://www.ncbi.nlm.nih.gov/pubmed/23270907?otool=fhcrclib
Zolla-Pazner S, Decamp AC, Cardozo T, Karasavvas N, Gottardo R, Williams C, et al. Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial. PloS one. 2013;8(1):e53629.
http://www.ncbi.nlm.nih.gov/pubmed/23349725?otool=fhcrclib
